All Stories

  1. Mycobacterial Lipids Induce Calcium Mobilization and Degranulation of Mast Cells
  2. Both B-1a and B-1b cells exposed to Mycobacterium tuberculosis lipids differentiate into IgM antibody-secreting cells
  3. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  4. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  5. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  6. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  7. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  8. Ascertaining fetal Zika virus infection based on IgM antibody test in endemic settings
  9. Total IgM and Anti-Phosphatidylcholine IgM Antibody Secretion Continue After Clearance of Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection
  10. Water quality effects of intermittent water supply in Arraiján, Panama
  11. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  12. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  13. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  14. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  15. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  16. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  17. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  18. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
  19. Mycobacterium bovis in Panama, 2013
  20. Dyspnoea, weight loss, fever, and headache caused by extrapulmonary tuberculosis in a prison inmate
  21. Storage in ultra-low-temperature decreases the levels of IgM anticardiolipin antibody in serum samples from tuberculosis patients
  22. Mycobacterium tuberculosis Isolates from Single Outpatient Clinic in Panama City Exhibit Wide Genetic Diversity
  23. Tuberculosis remains a challenge despite economic growth in Panama [Notes from the field]
  24. Enzymatic and endpoint methods yield comparable adenosine deaminase activity in pleural fluid samples
  25. Antiphospholipid IgM antibody response in acute and chronicMycobacterium tuberculosismouse infection model
  26. Serum samples can be substituted by plasma samples for the diagnosis of paratuberculosis
  27. High clustering rates of multidrug-resistant Mycobacterium tuberculosisgenotypes in Panama
  28. Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response
  29. An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis
  30. Mce2 operon mutant strain of Mycobacterium tuberculosis is attenuated in C57BL/6 mice